. The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden?. Pharmacoeconomics. 2005;23(3):227-42. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.